Congratulations! What a great achievement! 🎉

Please contact Dr Meng via email (xlmeng@liverpool.ac.uk) for informal discussions about the project. @LivUniISMIB @pandtuol

Check out our latest paper by @Megan_Ford_2021 on Selective HLA Class II Allele-Restricted Activation of Atabecestat Metabolite-Specific Human T-Cells published in @ChemResTox 🧫🥼🔬

Last week @Elsie_Clarke_ and Eleanor Saville presented their work at the EUROTOX Congress held in Copenhagen! They had the opportunity to listen to interesting talks and connect with several accomplished toxicologists 🔬🧬

Great to see work from @SophieGrice5, Liam Farrell, Georgia wells and Sean Hammond published in @ToxSci on how immune checkpoint blockade lowers the threshold of naïve T-cell priming to drug-associated antigens in a dose-dependent fashion 🥼🔬

Check out our latest paper from @SophieGrice5 and Sean Hammond outlining a case of omeprazole associated atypical DRESS with positive in-vitro diagnostic testing to multiple proton pump inhibitors 👩🏻‍🔬🧫

Have a read of our latest review, published in Chemical Research in Toxicology by @SophieGrice5, Sean Hammond and @AOlssonBrown on how drug-drug interactions can impact the safety of immune checkpoint inhibitors!

Great to see @Dr_paulthomson and Liam Farrells collaborative COVID-19 vaccine work with Oxford now published in the British journal of haematology

We had the pleasure of hosting the 11th joint ITCASS and ERGECD meeting here in Liverpool. We heard talks from scientists all over the globe from the fields of immunotoxicology, skin toxicology and immunology, contact dermatitis and inflammation 🥼🔬🦠

Last week was a busy week for the Naisbitt group starting off in Sheffield with the ARDAT general assembly where Luisa Hering presented her work on investigating the cellular immunogenicity of AAVs for gene therapies 🧬💉🔬

Congratulations @josh_gardner95 for being awarded the BSI career enhancing grant! 🔬🧪🥼

Have a read of our most recent paper by @josh_gardner95, @SophieGrice5 and Luisa Hering published in @Nature_NPJ Vaccines looking at the identification of cross reactive T cell responses in adenovirus based COVID-19 vaccines

Read our latest paper from @josh_gardner95 published in @ClinExpAllergy on the application of glycolysis to measure and detect the activation of drug-specifc T-cells.

What’s the tea? Only our latest paper out in @ChemResTox! You don’t want to miss our latest research into Green Tea Extract induced liver injury. Congratulations @JamesLine14 @SerateAli and @SophieGrice5 🥼🍵

Please contact Dr Meng via email (xlmeng@liverpool.ac.uk) for informal discussions about the project. @LivUniISMIB @pandtuol @NLD_BBSRCDTP

Please contact Dr Meng via email (xlmeng@liverpool.ac.uk) for informal discussions about the project. @LivUniISMIB @pandtuol 💊🧪